Search
Travere Therapeutics Inc
TVTXAdd to Watchlist
53.050USD
-0.220-0.41%
Market hours 10/15, 14:03（ET）
4.93BMarket Cap
LossP/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D
Today
-0.41%
5 Days
-0.73%
1 Month
-19.36%
6 Months
+25.92%
Year to Date
+38.84%
1 Year
+102.95%
Key Figures
53.720Open
55.550High
126.28KVolume
LossP/E TTM
22.61P/E Dynamic
--Dividend TTM
0.14%Turnover Ratio
53.270Prev. Close
51.530Low
6.89MTurnover
LossP/E Static
201.17P/B
0.00%Div Yield TTM
-8.27%ROA
68.73052wk High
0.10Volume Ratio
-321.55MNet Profit
92.99MShares
-0.2236EPS TTM
1.14Beta
-69.38%ROE
22.59052wk Low
7.55%Amplitude
88.96%Gross Margin
4.93BMarket Cap
3.42Reward/Risk
4.09%Risk Rate
Travere Therapeutics Inc's Score
-0.20vs previous score
Forecast8.67
Financial Health7.66
Technical4.20
Valuation Dimensions9.74
Institutional Confidence10.00
Risk Assessment6.73
Media Coverage
Coverage Level
Very Low
Very High
No data
Analyst Rating
Travere Therapeutics Inc Technical Analysis
Technical Indicators
Sell
Summary
Sell
Moving Average
Sell
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-0.37/-0.14
Revenue / Forecast
169.58M/159.59M
Travere Therapeutics Inc Profile
SectorBiotechnology & Medical Research
Ticker SymbolTVTX
Number of employees385
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| Janus Henderson Investors | 11.30% |
| BlackRock Institutional Trust Company, N.A. | 6.98% |
| Fidelity Management & Research Company LLC | 6.32% |
| State Street Investment Management (US) | 5.12% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 49.74% |
| Investment Advisor/Hedge Fund | 33.58% |
| Hedge Fund | 20.55% |
| Research Firm | 5.84% |
Related Instruments
+4.79%
+0.63%
+2.10%
+0.51%
+2.74%
+3.28%
+3.24%
+3.74%
+3.59%
+1.71%
+2.57%
+2.94%
+1.88%
+2.67%
+1.46%
+5.30%
+2.94%
+3.34%
+1.62%
+4.50%Popular Instruments
52131.400
+536.800 (+1.04%)
29784.300
-135.900 (-0.45%)
7728.800
+11.800 (+0.15%)
13383.000
+11.000 (+0.08%)
65382.000
-929.000 (-1.40%)
6169.500
+7.800 (+0.13%)
96.894
+2.691 (+2.86%)
343.870
+0.910 (+0.27%)
217.420
-3.880 (-1.75%)
4157.170
+52.460 (+1.28%)
FAQs
What is the current price of Travere Therapeutics Inc (TVTX)?
The current price of Travere Therapeutics Inc (TVTX) is 53.27.
What is the symbol of Travere Therapeutics Inc?
The ticker symbol of Travere Therapeutics Inc is TVTX.
What is the 52-week high of Travere Therapeutics Inc?
The 52-week high of Travere Therapeutics Inc is 68.73.
What is the 52-week low of Travere Therapeutics Inc?
The 52-week low of Travere Therapeutics Inc is 22.59.
What is the market capitalization of Travere Therapeutics Inc?
The market capitalization of Travere Therapeutics Inc is 4.95B.
Is Travere Therapeutics Inc (TVTX) currently rated as Buy, Hold, or Sell?
According to analysts, Travere Therapeutics Inc (TVTX) has an overall rating of Buy, with a price target of 74.08.
What is the Earnings Per Share (EPS TTM) of Travere Therapeutics Inc (TVTX)?
The Earnings Per Share (EPS TTM) of Travere Therapeutics Inc (TVTX) is -0.22.